We are proud to announce great news: Hermes Medical Solutions, the leading company when it comes to imaging software in Nuclear Medicine and Molecular Imaging, signed an agreement to license our worldwide used decidemedical platform. Through the collaboration, a seamless data flow can be utilized, allowing sites to safely transfer their image data (in DICOM format) via the web based decidemedical platform to the image analysis and processing servers of Hermes Medical Solutions. International research projects and clinical studies will now profit from a most safe transfer and efficient workflow solution in combination with the best tools available in Nuclear Medicine when it comes to providing vendor neutral, multimodality software for most innovative diagnostic and discovery of personalized treatment options for patients.
The Stockholm-based company has been recognized for clinical excellence and innovation for over 40 years, providing independent, vendor-neutral software solutions in Molecular Imaging and Nuclear Medicine.
We are very much looking forward to expanding our activities into the Nuclear Medicine market with Hermes Medical Solutions!